Try our Advanced Search for more refined results
April 27, 2011
Track this case
J. Frederick Motz
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.Additional or older documents may be available in Pacer.
Genzyme Corp. on Wednesday filed suit in Maryland accusing Endo Pharmaceuticals Inc. of infringing its patent covering Renvela by seeking approval to sell a generic version of the kidney disease treatment before the patent expires.
Already a subscriber? Click here to login